Free. Unsubscribe any time.
Axsome Therapeutics, Inc. (AXSM)
Axsome Therapeutics, Inc. filed 32 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 9 reporting owners, covering 57 transactions and 1,070,875 shares. 32 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 9 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-09-03, came 27 days after the one before it (2026-08-07) and reports 3 transactions against 6 in the filing before it.
- The sales it reports total 10,000 shares, 39,664 fewer than the 49,664 in the filing before it.
- Its 32 plan statements rank 187th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 3 have more plan statements on file than it and 7 have fewer.
- Its 32 filings on file run from 2025-02-14 to 2026-09-03, and state no plan adoption date.
Trades in Axsome Therapeutics, Inc. 57
- Pizzie Nick — 2025-02-13 · S · 12,000 shares
- Pizzie Nick — 2025-02-14 · S · 3,000 shares
- Coleman Mark — 2025-05-27 · S · 3,750 shares
- Jacobson Mark L. — 2025-05-27 · S · 20,673 shares
- Coleman Mark — 2025-05-28 · S · 3,750 shares
- Jacobson Mark L. — 2025-05-28 · S · 20,000 shares
- Jacobson Mark L. — 2025-06-09 · S · 25,000 shares
- Murdock Hunter R. — 2025-06-16 · S · 7,500 shares
- Murdock Hunter R. — 2025-06-17 · S · 7,500 shares
- Murdock Hunter R. — 2025-06-18 · S · 7,500 shares
- Murdock Hunter R. — 2025-06-20 · S · 7,500 shares
- Murdock Hunter R. — 2025-06-23 · S · 6,014 shares
Adoption dates in Axsome Therapeutics, Inc. 0
Results prints in Axsome Therapeutics, Inc. 9
- 2025-01-13
- 2025-02-18
- 2025-05-05
- 2025-08-04
- 2025-11-03
- 2026-01-12
- 2026-02-23
- 2026-05-04
- 2026-08-10
Trades before a print in Axsome Therapeutics, Inc. 7
- 0 days before the 2025-11-03 print — 2025-11-03 · S · TABUTEAU HERRIOT · 91,705 shares
- 0 days before the 2026-05-04 print — 2026-05-04 · S · Jacobson Mark L. · 4,517 shares
- 4 days before the 2025-02-18 print — 2025-02-14 · S · Pizzie Nick · 3,000 shares
- 4 days before the 2026-08-10 print — 2026-08-06 · S · TABUTEAU HERRIOT · 4,660 shares
- 5 days before the 2025-02-18 print — 2025-02-13 · S · Pizzie Nick · 12,000 shares
- 5 days before the 2026-01-12 print — 2026-01-07 · S · TABUTEAU HERRIOT · 31,261 shares
- 5 days before the 2026-08-10 print — 2026-08-05 · S · TABUTEAU HERRIOT · 45,004 shares
- 6 days before the 2026-01-12 print — 2026-01-06 · S · TABUTEAU HERRIOT · 29,450 shares
- 7 days before the 2026-01-12 print — 2026-01-05 · S · TABUTEAU HERRIOT · 78,703 shares
- 12 days before the 2026-01-12 print — 2025-12-31 · S · Saad Mark E · 6,231 shares
- 12 days before the 2026-01-12 print — 2025-12-31 · S · Saad Mark E · 31,346 shares
- 12 days before the 2026-05-04 print — 2026-04-22 · S · Maizel Ari · 7,500 shares
Interval to Axsome Therapeutics, Inc.’s next reported results date
How the interval and sources are counted →
- 7within 5 days
- 9within 10 days
- 0shortest, days
- 1no later print
- Pizzie Nick 2025-02-13 · S · 5 days before the 2025-02-18 print · Chief Financial Officer
- Pizzie Nick 2025-02-14 · S · 4 days before the 2025-02-18 print · Chief Financial Officer
- TABUTEAU HERRIOT 2025-11-03 · S · 0 days before the 2025-11-03 print · Chief Executive Officer
- TABUTEAU HERRIOT 2026-01-05 · S · 7 days before the 2026-01-12 print · Chief Executive Officer
- TABUTEAU HERRIOT 2026-01-06 · S · 6 days before the 2026-01-12 print · Chief Executive Officer
- TABUTEAU HERRIOT 2026-01-07 · S · 5 days before the 2026-01-12 print · Chief Executive Officer
- Jacobson Mark L. 2026-05-04 · S · 0 days before the 2026-05-04 print · Chief Operating Officer
- TABUTEAU HERRIOT 2026-08-05 · S · 5 days before the 2026-08-10 print · Chief Executive Officer
- TABUTEAU HERRIOT 2026-08-06 · S · 4 days before the 2026-08-10 print · Chief Executive Officer
Reported results dates on file
- 2025-01-13
- 2025-02-18
- 2025-05-05
- 2025-08-04
- 2025-11-03
- 2026-01-12
- 2026-02-23
- 2026-05-04
- 2026-08-10
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.